Korea Arlico Pharm Co.,Ltd.

KOSDAQ:A260660 Stock Report

Market Cap: ₩77.6b

Korea Arlico PharmLtd Dividend

Dividend criteria checks 0/6

Korea Arlico PharmLtd does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.1%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share₩199.71
Dividend yield forecast in 3Yn/a

Recent dividend updates

Recent updates

Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Mar 24
Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Mar 02
Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

Feb 12
Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Jan 25
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Jan 04
Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Dec 16
Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

Nov 25
Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A260660's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A260660's dividend payments have been increasing.


Dividend Yield vs Market

Korea Arlico PharmLtd Dividend Yield vs Market
How does A260660 dividend yield compare to the market?
SegmentDividend Yield
Company (A260660)n/a
Market Bottom 25% (KR)1.0%
Market Top 25% (KR)3.5%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast in 3 Years (A260660)n/a

Notable Dividend: Unable to evaluate A260660's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A260660's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A260660's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A260660 has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.